Dr. María Pérez-Vázquez is a clinical microbiologist and senior researcher at the Instituto de Salud Carlos III (ISCIII). Her scientific career focuses on antimicrobial resistance (AMR), combining clinical and genomic approaches. She has conducted most of her research at the Antibiotics Laboratory of the National Center for Microbiology (CNM-ISCIII), with additional experience in hospital settings and a one-year research stay at the Wellcome Sanger Institute (UK), a global leader in genomics. She has actively participated in European and national research and surveillance networks (EARS-Net, EURGen-RefLabCap, REIPI, CIBERINFEC). Initially focused on non-WGS methods (1996–2012), she contributed to over 15 national and 6 European projects and published 46 articles. Since 2012, she has led the implementation of WGS-based surveillance in Spain, including RedLabRA. She has coordinated 9 national and 1 European projects, published 33 articles, and described high-risk clones, outbreaks, and resistance mechanisms. She leads national surveillance programs for Haemophilus influenzae and AMR-WGS. In teaching, she coordinates the "Vaccine-preventable diseases" course at the Master's in Public Health Microbiology (UAH–ISCIII). She has mentored PhD, MSc, and postdoctoral researchers. Her work has significantly contributed to integrating research, surveillance, and public health response in Spain.